NuvaRing is a popular non-oral contraceptive device that is implanted every several weeks to provide birth control without the need of a daily pill. Each year the device is prescribed more than 5 million times.
Unfortunately, recent studies have shown that the direct chemical hormone release into the bloodstream of vaginal devices such as this can increase the risk of serious conditions like blood clots and NuvaRing DVT.
Pulmonary embolism occurs when a blood clot breaks free and passes through the circulatory system into the arteries of the lungs. It can then block the flow of oxygen rich blood to parts of the lungs causing injury or even death.
While pulmonary embolism can occur naturally, experts have discovered that the active ingredient in Yaz, drospirenone, can cause as much as a 75% increase in the risk of blood clots and consequentially, Yaz pulmonary embolism.
It is important for anyone suffering a blockage in the lungs to receive medical treatment as soon as possible. Some of the common symptoms of Yaz pulmonary embolism include:
Experts fear that thousand of women may have suffered such side effects since Bayer Pharmaceuticals, the maker of Yaz, failed to properly warn of the risks. Many of these have now filed a lawsuit and recovered with a Yaz settlement.
The makers of NuvaRing, Organon Pharmaceuticals and Merck, actually marketed the device as a safer alternative as it contained lower overall doses of hormones. However, since they failed to adequately test for the affects of bloodstream absorption or warn of the risks, they are liable for the damages caused.
If you or a loved one suffered a DVT or blood clot injury after using a NuvaRing device, you may be entitled to substantial compensation. It is important to speak with a lawyer about your legal options as soon as possible. Contact us today.
Researchers in Europe and the United States have discovered that vaginal ring contraceptive devices like NuvaRing can significantly increase the risk of blood clots, which can cause stroke, deep vein thrombosis (DVT) and pulmonary embolism.
The FDA has received more than 1,000 reports of NuvaRing patients suffering injury or death from blood clots. Last year, they released a study warning that vaginal rings could increase blood clot risks by as much as 56% compared to traditional birth control pills.
This year, the New England Journal of Medicine and British Medical Journal have both published studies from Danish researchers showing that devices like NuvaRing can increase the risk of blood clots by as much as 90% over oral contraceptives, or as much as 650% over no hormone use.
Nearly 1,000 women have already filed a lawsuit for blood clot injuries like NuvaRing DVT. A federal panel has now consolidated the cases into a federal Multi District Litigation court due to the number of claims expected.
Attorneys with the NuvaRing Litigation Group have helped thousands of families recover after drug and medical device injuries and are currently helping victims of NuvaRing injury. These same attorneys are available to discuss your case today.
Before you choose an attorney, make sure they are qualified for this type of complex lawsuit, have experience fighting large drug companies, and have the resources to finish your case.
The NuvaRing Resource Center works only with the top defective drug law firms in the country to make sure your case is handled properly and you recover quickly.
Contact us today for more information on the side effects, research and litigation related to NuvaRing DVT, or to speak with a lawyer. We are available 24 hours a day to provide help.
|Blood Clots||Local Help||Legal Options|